James L. Stanton

1.2k total citations
27 papers, 891 citations indexed

About

James L. Stanton is a scholar working on Organic Chemistry, Molecular Biology and Pharmacology. According to data from OpenAlex, James L. Stanton has authored 27 papers receiving a total of 891 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Organic Chemistry, 12 papers in Molecular Biology and 7 papers in Pharmacology. Recurrent topics in James L. Stanton's work include Enzyme function and inhibition (7 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (4 papers) and Chemical Synthesis and Analysis (3 papers). James L. Stanton is often cited by papers focused on Enzyme function and inhibition (7 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (4 papers) and Chemical Synthesis and Analysis (3 papers). James L. Stanton collaborates with scholars based in Switzerland and United States. James L. Stanton's co-authors include Joseph E. Babiarz, Jeanette M. Wood, Michael Ackerman, Karl G. Hofbauer, Barry M. Trost, Georges Haas, H. Rüeger, Leoluca Criscione, Peter Bühlmayer and Gerard C. Mazzenga and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Medicinal Chemistry and Tetrahedron Letters.

In The Last Decade

James L. Stanton

25 papers receiving 828 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
James L. Stanton Switzerland 19 483 424 131 118 114 27 891
C. John Blankley United States 17 510 1.1× 419 1.0× 68 0.5× 90 0.8× 114 1.0× 33 1.0k
Walter Fuhrer Switzerland 13 749 1.6× 456 1.1× 148 1.1× 72 0.6× 282 2.5× 18 1.2k
Peter Herold Switzerland 13 572 1.2× 474 1.1× 76 0.6× 86 0.7× 150 1.3× 17 905
Takehiko Naka Japan 19 621 1.3× 733 1.7× 229 1.7× 104 0.9× 411 3.6× 38 1.5k
Alexander Chucholowski Germany 14 670 1.4× 537 1.3× 36 0.3× 95 0.8× 89 0.8× 24 956
Y. Kawamatsu Japan 18 476 1.0× 706 1.7× 162 1.2× 192 1.6× 26 0.2× 44 1.2k
Yasuteru Iijima Japan 19 328 0.7× 465 1.1× 70 0.5× 243 2.1× 160 1.4× 39 994
Claudio F. Sturino Canada 18 644 1.3× 355 0.8× 76 0.6× 166 1.4× 43 0.4× 29 1.1k
Steven A. Boyd United States 18 320 0.7× 322 0.8× 85 0.6× 63 0.5× 71 0.6× 34 739
Edward W. Petrillo United States 18 476 1.0× 439 1.0× 37 0.3× 35 0.3× 108 0.9× 26 936

Countries citing papers authored by James L. Stanton

Since Specialization
Citations

This map shows the geographic impact of James L. Stanton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James L. Stanton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James L. Stanton more than expected).

Fields of papers citing papers by James L. Stanton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James L. Stanton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James L. Stanton. The network helps show where James L. Stanton may publish in the future.

Co-authorship network of co-authors of James L. Stanton

This figure shows the co-authorship network connecting the top 25 collaborators of James L. Stanton. A scholar is included among the top collaborators of James L. Stanton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James L. Stanton. James L. Stanton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Stanton, James L., et al.. (2024). Ranolazine toxicity precipitating seizure in the elderly. BMJ Case Reports. 17(12). e260134–e260134.
2.
Coppola, Gary M., Paivi J. Kukkola, James L. Stanton, et al.. (2005). Perhydroquinolylbenzamides as Novel Inhibitors of 11β-Hydroxysteroid Dehydrogenase Type 1. Journal of Medicinal Chemistry. 48(21). 6696–6712. 30 indexed citations
3.
Stanton, James L., et al.. (2000). Synthesis and biological activity of phenoxyphenyl oxamic acid derivatives related to l-thyronine. Bioorganic & Medicinal Chemistry Letters. 10(15). 1661–1663. 15 indexed citations
4.
Bebernitz, Gregory R., Thomas D. Aicher, James L. Stanton, et al.. (2000). Anilides of (R)-Trifluoro-2-hydroxy-2-methylpropionic Acid as Inhibitors of Pyruvate Dehydrogenase Kinase. Journal of Medicinal Chemistry. 43(11). 2248–2257. 49 indexed citations
5.
Vlattas, Isidoros, et al.. (1997). The use of thioesters in solid phase organic synthesis. Tetrahedron Letters. 38(42). 7321–7324. 24 indexed citations
6.
Yokoyama, Naokata, Gordon N. Walker, Alan J. Main, et al.. (1995). Synthesis and Structure-Activity Relationships of Oxamic Acid and Acetic Acid Derivatives Related to L-Thyronine. Journal of Medicinal Chemistry. 38(4). 695–707. 51 indexed citations
7.
Vlattas, Isidoros, James L. Stanton, Albert Braunwalder, et al.. (1994). Identification of a Receptor-Binding Region in the Core Segment of the Human Anaphylatoxin C5a. Journal of Medicinal Chemistry. 37(17). 2783–2790. 8 indexed citations
8.
Stanton, James L., et al.. (1993). Heterocyclic lactam derivatives as dual angiotensin converting enzyme and neutral endopeptidase 24.11 inhibitors. Journal of Medicinal Chemistry. 36(24). 3829–3833. 24 indexed citations
9.
Satoh, Yoshitaka, James L. Stanton, Alan Hutchison, et al.. (1993). Substituted chromenes as potent, orally active 5-lipoxygenase inhibitors. Journal of Medicinal Chemistry. 36(23). 3580–3594. 29 indexed citations
10.
Wood, J M, Leoluca Criscione, Marc de Gasparo, et al.. (1989). CGP 38 560: orally active, low-molecular-weight renin inhibitor with high potency and specificity.. PubMed. 14(2). 221–6. 37 indexed citations
11.
Bühlmayer, Peter, Alessandro Caselli, Walter Fuhrer, et al.. (1988). Synthesis and biological activity of some transition-state inhibitors of human renin. Journal of Medicinal Chemistry. 31(9). 1839–1846. 90 indexed citations
12.
Wood, Jeanette M., James L. Stanton, & Karl G. Hofbauer. (1987). Inhibitors of Renin as Potential Therapeutic Agents. Journal of enzyme inhibition. 1(3). 169–185. 59 indexed citations
13.
Stanton, James L., et al.. (1985). Angiotensin converting enzyme inhibitors: structure-activity profile of 1-benzazepin-2-one derivatives. Journal of Medicinal Chemistry. 28(11). 1603–1606. 12 indexed citations
14.
Slade, Joel, et al.. (1985). Angiotensin converting enzyme inhibitors: 1,5-benzothiazepine derivatives. Journal of Medicinal Chemistry. 28(10). 1517–1521. 64 indexed citations
15.
Stanton, James L., et al.. (1985). Synthesis and biological properties of (carboxyalkyl)amino-substituted bicyclic lactam inhibitors of angiotensin converting enzyme. Journal of Medicinal Chemistry. 28(10). 1511–1516. 105 indexed citations
16.
Stanton, James L., et al.. (1983). Angiotensin converting enzyme inhibitors: 1-glutarylindoline-2-carboxylic acid derivatives. Journal of Medicinal Chemistry. 26(9). 1277–1282. 60 indexed citations
17.
Haas, Georges, James L. Stanton, & Tammo Winkler. (1981). The synthesis of heteroaromatic nitro compounds from 3‐nitrochromone. Journal of Heterocyclic Chemistry. 18(3). 619–622. 20 indexed citations
18.
Haas, Georges, et al.. (1981). The synthesis of pyridine derivatives from 3‐formylchromone. Journal of Heterocyclic Chemistry. 18(3). 607–612. 51 indexed citations
19.
Trost, Barry M., Joseph M. Timko, & James L. Stanton. (1978). An enantioconvergent approach to prostanoids. Journal of the Chemical Society Chemical Communications. 436–436. 23 indexed citations
20.
Trost, Barry M., et al.. (1971). Some aspects of terpene biosynthesis—a model. Journal of the Chemical Society D Chemical Communications. 0(24). 1639–1640. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by C. John Blankley Breakdown of academic impact, for papers by Walter Fuhrer Breakdown of academic impact, for papers by Peter Herold Breakdown of academic impact, for papers by Takehiko Naka Breakdown of academic impact, for papers by Alexander Chucholowski Breakdown of academic impact, for papers by Y. Kawamatsu Breakdown of academic impact, for papers by Yasuteru Iijima Breakdown of academic impact, for papers by Claudio F. Sturino Breakdown of academic impact, for papers by Steven A. Boyd Breakdown of academic impact, for papers by Edward W. Petrillo
Rankless by CCL
2026